GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Upper GI Tract/Pediatric Eosinophilic Esophagitis- ASGE Consensus: GIE | March 2026

Pediatric Eosinophilic Esophagitis- ASGE Consensus: GIE | March 2026

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated March 1, 2026

Quick Answer

Introduction Eosinophilic esophagitis (EoE) is a chronic, immune-mediated disease characterized by progressive esophageal inflammation that can evolve into fibrostenotic complications such as strictures and food impaction. Endoscopy plays a central role not only in diagnosis but also in long-term disease monitoring and therapeutic decision-making.


Introduction

Eosinophilic esophagitis (EoE) is a chronic, immune-mediated disease characterized by progressive esophageal inflammation that can evolve into fibrostenotic complications such as strictures and food impaction. Endoscopy plays a central role not only in diagnosis but also in long-term disease monitoring and therapeutic decision-making. This American Society for Gastrointestinal Endoscopy consensus document expands prior guidance by focusing on disease assessment, monitoring strategies, and pediatric-specific considerations, reflecting the evolving understanding of EoE as a lifelong condition requiring structured and multidisciplinary care.

Summary

This consensus emphasizes that eosinophilic esophagitis should be approached as a disease requiring integrated assessment across symptoms, endoscopic findings, and histology, as no single domain reliably reflects disease activity. Initial diagnostic endoscopy should be performed off treatment to avoid false-negative results and must include adequate biopsies, with at least six samples from multiple esophageal levels. The guideline highlights that symptoms alone are unreliable due to adaptive eating behaviors and poor correlation with inflammation, reinforcing the need for objective monitoring.

A key advancement is the growing role of less invasive monitoring tools such as transnasal endoscopy and esophageal string testing, which can reduce procedural burden but are not suitable for initial diagnosis or for patients with suspected strictures. Structured monitoring intervals are recommended based on treatment type, with earlier reassessment for dietary and pharmacologic therapies and longer intervals for biologics. The document also underscores that endoscopic detection of strictures is often insensitive, requiring adjunctive methods such as esophagography or functional lumen assessment.

In pediatric populations, early recognition based on feeding difficulties and growth concerns is critical, and transition planning to adult care is essential to prevent loss of follow-up. The guideline strongly emphasizes that gaps in monitoring are associated with progression to fibrostenosis, making continuous follow-up a cornerstone of care.

Conclusion

This ASGE consensus provides a comprehensive, practice-oriented framework for the endoscopic management of eosinophilic esophagitis beyond diagnosis. The key message is that effective care requires structured, longitudinal monitoring using a combination of clinical, endoscopic, and histologic parameters, with selective integration of less invasive tools. By standardizing assessment and minimizing gaps in care, these recommendations aim to prevent disease progression and improve long-term outcomes in both adult and pediatric patients.

Related Q&A

Basal Crypt Dysplasia in Barrett's Esophagus: GUT | July 2026

Introduction: Barrett's esophagus (BE) is the principal precursor of esophageal adenocarcinoma. Early detection of neoplastic transformation is essential for preventing cancer progression. This review discusses basal crypt dysplasia (CD), an emerging histological entity that may...

High-Resolution Impedance Manometry after POEM: AJG | May 2026

Introduction: Assessing esophageal clearance after peroral endoscopic myotomy (POEM) is essential for evaluating treatment success in achalasia. Timed barium esophagram (TBE) is the current standard, but high-resolution impedance manometry (HRiM) may provide a radiation-free physiological...

Magnetic Sphincter Augmentation Provides Durable GERD Control : Ann Surg | Jun 2026

Introduction: Magnetic sphincter augmentation (MSA) has emerged as an effective surgical option for patients with gastroesophageal reflux disease (GERD) who continue to experience symptoms despite medical therapy. By augmenting lower esophageal sphincter function while preserving...

New Strategies Needed for Resistant H. pylori : Indian J Gastroenterol | Jun 2026

Introduction: Helicobacter pylori infection affects more than half of the global population and remains a major cause of peptic ulcer disease, gastric mucosal inflammation, and gastric cancer. Successful eradication is a cornerstone of gastrointestinal practice,...

Vonoprazan–Tetracycline Dual Therapy Simplifies H. pylori Rescue Treatment : Gastroenterology | June 2026

Introduction: Helicobacter pylori Infection eradication after prior treatment failure remains a major therapeutic challenge due to increasing antibiotic resistance, poor tolerability of multidrug regimens and declining adherence rates. Simplified rescue strategies with improved safety and...

H. pylori Eradication Reduces Cancer but Mortality Benefit Remains Fragile : Gastroenterology | June 2026

Introduction Helicobacter pylori Infection eradication is widely accepted as a key strategy for prevention of Gastric Cancer. Large meta-analyses have consistently shown reductions in gastric cancer incidence following eradication therapy, supporting global screening and treatment...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer